Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1855 1
1856 1
1860 1
1862 1
1871 3
1891 1
1892 1
1911 1
1945 1
1946 5
1947 4
1948 1
1949 8
1950 2
1951 3
1952 1
1954 2
1956 3
1957 2
1958 5
1959 4
1960 3
1961 2
1962 2
1963 2
1964 1
1965 4
1966 8
1967 4
1968 3
1969 7
1970 7
1971 7
1972 10
1973 4
1974 11
1975 5
1976 8
1977 16
1978 5
1979 14
1980 9
1981 7
1982 16
1983 16
1984 17
1985 18
1986 12
1987 20
1988 14
1989 22
1990 25
1991 20
1992 25
1993 32
1994 29
1995 34
1996 27
1997 28
1998 38
1999 23
2000 35
2001 20
2002 34
2003 36
2004 35
2005 45
2006 50
2007 57
2008 65
2009 85
2010 87
2011 89
2012 97
2013 106
2014 102
2015 142
2016 151
2017 138
2018 132
2019 147
2020 194
2021 240
2022 238
2023 211
2024 242
2025 218
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,200 results

Results by year

Filters applied: . Clear all
Page 1
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation.
Bhatt SP, Rabe KF, Hanania NA, Vogelmeier CF, Bafadhel M, Christenson SA, Papi A, Singh D, Laws E, Patel N, Yancopoulos GD, Akinlade B, Maloney J, Lu X, Bauer D, Bansal A, Abdulai RM, Robinson LB; NOTUS Study Investigators. Bhatt SP, et al. Among authors: robinson lb. N Engl J Med. 2024 Jun 27;390(24):2274-2283. doi: 10.1056/NEJMoa2401304. Epub 2024 May 20. N Engl J Med. 2024. PMID: 38767614 Clinical Trial.
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts.
Bhatt SP, Rabe KF, Hanania NA, Vogelmeier CF, Cole J, Bafadhel M, Christenson SA, Papi A, Singh D, Laws E, Mannent LP, Patel N, Staudinger HW, Yancopoulos GD, Mortensen ER, Akinlade B, Maloney J, Lu X, Bauer D, Bansal A, Robinson LB, Abdulai RM; BOREAS Investigators. Bhatt SP, et al. Among authors: robinson lb. N Engl J Med. 2023 Jul 20;389(3):205-214. doi: 10.1056/NEJMoa2303951. Epub 2023 May 21. N Engl J Med. 2023. PMID: 37272521 Clinical Trial.
Piriformis syndrome.
Lo JK, Robinson LR. Lo JK, et al. Among authors: robinson lr. Handb Clin Neurol. 2024;201:203-226. doi: 10.1016/B978-0-323-90108-6.00002-8. Handb Clin Neurol. 2024. PMID: 38697742 Review.
Updated Clinical Guidelines for Diagnosing Fetal Alcohol Spectrum Disorders.
Hoyme HE, Kalberg WO, Elliott AJ, Blankenship J, Buckley D, Marais AS, Manning MA, Robinson LK, Adam MP, Abdul-Rahman O, Jewett T, Coles CD, Chambers C, Jones KL, Adnams CM, Shah PE, Riley EP, Charness ME, Warren KR, May PA. Hoyme HE, et al. Among authors: robinson lk. Pediatrics. 2016 Aug;138(2):e20154256. doi: 10.1542/peds.2015-4256. Epub 2016 Jul 27. Pediatrics. 2016. PMID: 27464676 Free PMC article.
Treatment for Alzheimer's disease.
Fox NC, Belder C, Ballard C, Kales HC, Mummery C, Caramelli P, Ciccarelli O, Frederiksen KS, Gomez-Isla T, Ismail Z, Paquet C, Petersen RC, Perneczky R, Robinson L, Sayin O, Frisoni GB. Fox NC, et al. Among authors: robinson l. Lancet. 2025 Sep 27;406(10510):1408-1423. doi: 10.1016/S0140-6736(25)01329-7. Epub 2025 Sep 22. Lancet. 2025. PMID: 40997839 Free article. Review.
Type I IFN drives unconventional IL-1β secretion in lupus monocytes.
Caielli S, Balasubramanian P, Rodriguez-Alcazar J, Balaji U, Robinson L, Wan Z, Baisch J, Smitherman C, Walters L, Sparagana P, Nehar-Belaid D, Marches R, Nassi L, Stewart K, Fuller J, Banchereau JF, Gu J, Wright T, Pascual V. Caielli S, et al. Among authors: robinson l. Immunity. 2024 Nov 12;57(11):2497-2513.e12. doi: 10.1016/j.immuni.2024.09.004. Epub 2024 Oct 7. Immunity. 2024. PMID: 39378884
Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials.
Bhatt SP, Rabe KF, Hanania NA, Vogelmeier CF, Bafadhel M, Christenson SA, Papi A, Singh D, Laws E, Dakin P, Maloney J, Lu X, Bauer D, Bansal A, Abdulai RM, Robinson LB. Bhatt SP, et al. Among authors: robinson lb. Lancet Respir Med. 2025 Mar;13(3):234-243. doi: 10.1016/S2213-2600(24)00409-0. Epub 2025 Jan 31. Lancet Respir Med. 2025. PMID: 39900091 Clinical Trial.
3,200 results